A clinical trial evidence review of completed studies registered on ClinicalTrials.gov has systematically mapped the pipeline of emerging pharmacotherapies for HSDD, confirming bremelanotides position as the most advanced MC4R-targeting agent while identifying the next generation of melanocortin-based compounds progressing through early-phase development (PMID: 42254382)
CONCERN #5: POOR WOUND HEALING AND SCARRING Description: A simple cut takes weeks to heal, or a surgical scar remains raised, red, and uncomfortable long after the procedure
Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data
calcium: low-sugar yogurt, kefir, cheeses
Independent Wellness offers compounded Semaglutide injection plans starting at $149 per month for eligible patients, with provider access, labs, support, and medication delivery included in plan pricing